Among noncardioprotective antidiabetic agents, the use of DPP4i and TZD exhibited an increasing trend, whereas the use of SU showed a decreasing trend.
← all excerpts
Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With T2DM and ASCVD in South Korea.
1
—
—